Sarepta Therapeutics Inc (NASDAQ:SRPT) currently has a daily average trading volume of 5.37M but it saw 3993841 shares traded in last market. With a market cap of 1.90B USD, the company’s current market price of $19.37 came rising about 1.79 while comparing to the previous closing price of $19.03. In past 52 weeks, the stock remained buoying in the range of price level as high as $154.13 and as low as $16.88. In the recent trading on the day, stock has struck highest price mark of $18.9001 while lowest mark touched by it was $19.74.
TD Cowen downgraded its recommendation for the stock as a “Hold” from “Buy” on June 18, 2025 while assigning a price target of $24.
Over the week, SRPT’s stock price is moving 9.37% up while it is -54.96% when we observe its performance for the past one month. Year-to-date it is -87.23% down and over the past year, the stock is showing a downside performance of -84.07%.
The company is expected to be releasing its next quarterly report on 2025-May-06, for which analysts forecasted an EPS of 1.17 while estimate for next year EPS is -1.89. In next quarter, company is expected to be making quarterly sales of $498.91M as analysts are expecting the sales for current fiscal year at $2.27B and seeing the company making $2.28B in sales next year. Moreover, analysts are in estimates of $530.66M for current-quarter revenue.
Currently, Sarepta Therapeutics Inc’s total number of outstanding shares is 98.25M with 4.42% of that held by the insiders while 96.33% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -9.99% and return on equity (ROE) at -23.61%. It has a 6.94 of forward P/E ratio. Stock’s beta reads 0.45. Stock has a price to book (P/B) ratio of 1.67 while price to sale or P/S ratio amounts to 0.85. Its return on asset (ROA) is -7.43% on average.
